Key Insights

The Korea Continuous Glucose Monitoring (CGM) Devices market is projected to experience robust growth, with a market size of $84.24 million in 2025 and a Compound Annual Growth Rate (CAGR) of 9.40% from 2025 to 2033. This expansion is driven by several key factors. The increasing prevalence of diabetes in South Korea, coupled with a rising awareness of the benefits of CGM technology for improved diabetes management, is a significant driver. Technological advancements leading to smaller, more user-friendly, and accurate CGM devices are also fueling market growth. Furthermore, government initiatives promoting better healthcare access and technological adoption within the healthcare sector are creating a favorable environment for CGM market expansion. The market segmentation reveals significant contributions from major metropolitan areas like Seoul, Busan, and Incheon, reflecting higher diabetes prevalence and greater access to advanced medical technologies in these regions. The component segment is likely dominated by sensors, given their consumable nature and frequent replacement needs. Strong competition from key players like Dexcom, Eversense, Medtronic, Abbott, and Ascensia is driving innovation and fostering market competitiveness.

The forecast period (2025-2033) anticipates continued market growth, driven by sustained technological improvements, increased patient awareness, and expanding healthcare infrastructure. While precise regional breakdowns beyond the provided Korean provinces are unavailable, the US market's influence (given its inclusion in the data) suggests a global trend mirroring the Korean market's growth. Factors such as rising healthcare costs and potential reimbursement challenges could act as restraints, but the overall market outlook remains positive, driven by the compelling benefits of CGM technology in improving diabetes management and patient outcomes. Further research focusing on specific provincial market penetration and detailed sales data for each company would provide a more granular understanding of market dynamics.

Korea Continuous Glucose Monitoring (CGM) Devices Market Report: 2019-2033

This comprehensive report provides a detailed analysis of the Korea Continuous Glucose Monitoring (CGM) Devices market, offering invaluable insights for stakeholders including manufacturers, investors, and healthcare professionals. Covering the period from 2019 to 2033, with a base year of 2025, this report offers a thorough understanding of market dynamics, competitive landscapes, and future growth potential. The market is segmented by provinces (Seoul, Busan, Daegu Metropolitan City, Incheon Metropolitan City, Gwangju, and Other Provinces), components (Sensors and Durables – Receivers and Transmitters), and key players like Dexcom Inc, Eversense, Medtronic PLC, Abbott Diabetes Care Inc, and Ascensia. The report projects a market value of xx Million by 2033.

Korea Continuous Glucose Monitoring Devices Market Structure & Competitive Dynamics

The Korean CGM market exhibits a moderately concentrated structure, with a few dominant players and several emerging companies. The market's innovation ecosystem is driven by technological advancements in sensor technology, data analytics, and integration with insulin delivery systems. Regulatory frameworks, aligned with global standards, influence product approvals and market access. The market faces competition from alternative glucose monitoring methods, yet CGM's benefits are driving increased adoption. Mergers and acquisitions (M&A) activities are transforming the competitive landscape, with significant deals impacting market share and pricing. For instance, Medtronic PLC's acquisition of EOFlow significantly bolstered its product portfolio and market position.

• Market Concentration: Moderately concentrated, with the top three players holding approximately xx% market share in 2024.
• Innovation Ecosystem: Strong focus on miniaturization, improved accuracy, and seamless data integration.
• Regulatory Framework: Aligned with international standards, facilitating market entry for innovative products.
• M&A Activity: Significant deals, such as Medtronic's acquisition of EOFlow (xx Million deal value estimated), are reshaping the market.
• End-User Trends: Increasing preference for non-invasive, user-friendly, and data-driven CGM systems.

Korea Continuous Glucose Monitoring Devices Market Industry Trends & Insights

The Korean CGM market is experiencing robust growth, driven by rising diabetes prevalence, increasing healthcare expenditure, and growing awareness of the benefits of continuous glucose monitoring. Technological advancements, including improved sensor accuracy, longer wear times, and smartphone integration, are further fueling market expansion. Consumer preferences are shifting towards smaller, more comfortable devices with enhanced data visualization and remote monitoring capabilities. The market's competitive dynamics are characterized by intense innovation, strategic partnerships, and pricing pressures. The CAGR for the forecast period (2025-2033) is estimated at xx%, with market penetration expected to reach xx% by 2033. The rising price of Freestyle Libre due to inflation and raw material costs presents a challenge, impacting affordability.

Dominant Markets & Segments in Korea Continuous Glucose Monitoring Devices Market

The Seoul metropolitan area holds the largest market share in the Korean CGM market due to its high population density, advanced healthcare infrastructure, and higher disposable incomes. Other major cities like Busan, Daegu, and Incheon also contribute significantly to market growth. The Sensors segment dominates the component market, representing approximately xx% of the market value, driven by ongoing innovation in sensor technology and the need for frequent sensor replacements. The Durables (Receivers and Transmitters) segment is also witnessing substantial growth, with advancements in device design and connectivity.

• Key Drivers for Seoul's Dominance:
  • High prevalence of diabetes
  • Well-developed healthcare infrastructure
  • High concentration of specialized diabetes clinics and hospitals
  • Higher disposable incomes compared to other regions

Korea Continuous Glucose Monitoring Devices Market Product Innovations

Recent product innovations focus on improving accuracy, minimizing invasiveness, extending wear times, and enhancing data integration. CGM devices are increasingly incorporating features like advanced algorithms for predictive analytics, integration with insulin pumps, and remote patient monitoring capabilities. These innovations are improving patient outcomes and driving broader market adoption, offering competitive advantages to companies that consistently innovate.

Report Segmentation & Scope

This report segments the Korean CGM market by:

• Provinces: Seoul, Busan, Daegu Metropolitan City, Incheon Metropolitan City, Gwangju, and Other Provinces. Each province's market size and growth trajectory are analyzed based on factors like diabetes prevalence, healthcare infrastructure, and economic conditions. Seoul exhibits the highest growth rate.

• Components: Sensors and Durables (Receivers and Transmitters). Detailed analysis of each component's market size, growth rate, and competitive dynamics is provided. The sensor segment shows stronger growth potential due to its consumable nature.

Key Drivers of Korea Continuous Glucose Monitoring Devices Market Growth

The Korean CGM market's growth is propelled by several factors: the increasing prevalence of diabetes, government initiatives to improve diabetes management, rising healthcare spending, and technological advancements leading to more accurate, user-friendly, and affordable devices. The expanding geriatric population also contributes significantly to market growth.

Challenges in the Korea Continuous Glucose Monitoring Devices Market Sector

The market faces challenges such as high device costs, reimbursement limitations impacting affordability, and the need for skilled healthcare professionals to manage CGM data effectively. Supply chain disruptions and intense competition also impact market growth. The recent 10% price increase of Abbott Freestyle Libre exemplifies cost-related challenges.

Leading Players in the Korea Continuous Glucose Monitoring Devices Market Market

• Dexcom Inc
• Eversense
• Medtronic PLC
• Abbott Diabetes Care Inc
• Ascensia

Key Developments in Korea Continuous Glucose Monitoring Devices Market Sector

• May 2023: Medtronic PLC acquired EOFlow Co. Ltd., expanding its product portfolio and capabilities in insulin delivery and CGM.
• Jan 2023: Adela announced a 10% price increase for Abbott Freestyle Libre due to inflation and rising raw material costs.

Strategic Korea Continuous Glucose Monitoring Devices Market Market Outlook

The Korean CGM market holds significant potential for growth, driven by technological innovation, rising diabetes prevalence, and supportive government policies. Strategic opportunities exist for companies focusing on developing cost-effective, user-friendly devices, expanding distribution networks, and forging strategic partnerships with healthcare providers. The market is poised for continued expansion, with opportunities for both established players and new entrants.

Korea Continuous Glucose Monitoring Devices Market Segmentation

• 1. Component
  • 1.1. Sensors
  • 1.2. Durables (Receivers and Transmitters)
• 2. Provinces (Quantitative Analysis)
  • 2.1. Seoul
  • 2.2. Busan
  • 2.3. Daegu Metropolitan City
  • 2.4. Incheon Metropolitan City
  • 2.5. Gwangju
  • 2.6. Other Provinces

Korea Continuous Glucose Monitoring Devices Market Segmentation By Geography

• 1. North America
  • 1.1. United States
  • 1.2. Canada
  • 1.3. Mexico
• 2. South America
  • 2.1. Brazil
  • 2.2. Argentina
  • 2.3. Rest of South America
• 3. Europe
  • 3.1. United Kingdom
  • 3.2. Germany
  • 3.3. France
  • 3.4. Italy
  • 3.5. Spain
  • 3.6. Russia
  • 3.7. Benelux
  • 3.8. Nordics
  • 3.9. Rest of Europe
• 4. Middle East & Africa
  • 4.1. Turkey
  • 4.2. Israel
  • 4.3. GCC
  • 4.4. North Africa
  • 4.5. South Africa
  • 4.6. Rest of Middle East & Africa
• 5. Asia Pacific
  • 5.1. China
  • 5.2. India
  • 5.3. Japan
  • 5.4. South Korea
  • 5.5. ASEAN
  • 5.6. Oceania
  • 5.7. Rest of Asia Pacific